Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: Findings from the health, aging and body composition study

Journal of the American Geriatrics Society

Volumn 57, Issue 2, 2009, Pages 243-250

  Wright, Rollin M ^a,b   Roumani, Yazan F ^b   Boudreau, Robert ^c   Newman, Anne B ^b,c   Ruby, Christine M ^a   Studenski, Stephanie A ^b,d   Shorr, Ronald I ^d   Bauer, Douglas C ^e   Simonsick, Eleanor M ^f,g   Hilmer, Sarah N ^g,h   Hanlon, Joseph T ^a,b,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NATIONAL INSTITUTE ON AGING   (United States)

^h UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Aged; Cognition; Medications

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; NEUROLEPTIC AGENT; OPIATE ANTAGONIST;

AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LONG TERM CARE; MALE; RISK FACTOR; TREATMENT DURATION;

AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BRAIN; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MALE; RECEPTORS, GABA-A; RECEPTORS, OPIOID; TIME FACTORS;

EID: 58849139236     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.02127.x     Document Type: Article

References (53)

1. Hanlon JT, Fillenbaum GG, Burchett B et al. Drug-use patterns among black and nonblack community-dwelling elderly. Ann Pharmacother 1992 26 : 679 685.
2. Kotlyar M, Lindblad CI, Gray SL et al. Psychiatric manifestations of medications in the elderly. In : Agronin ME, Maletta GJ, eds. Principles and Practice of Geriatric Psychiatry. Philadelphia : Lippincott Williams & Wilkins, 2006, pp 605 616.
3. Larson EB, Kukull WA, Buchner D et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 1987 107 : 169 173.
4. Marcantonio ER, Goldman L, Mangione CM et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA 1994 271 : 134 139.
5. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999 16 : 15 28.
6. Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: The Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002 22 : 285 293.
7. Hanlon JT, Horner RD, Schmader KE et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 1998 64 : 684 692.
8. Gray SL, LaCroix AZ, Hanlon JT et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006 54 : 224 230.
9. Marcantonio ER, Juarez G, Goldman L et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994 272 : 1518 1522.
10. Pomara N, Deptula D, Medel M et al. Effects of diazepam on recall memory: Relationship to aging, dose, and duration of treatment. Psychopharmacol Bull 1989 25 : 144 148.
11. Cao Y-J, Mager D, Simonsick EM et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 2008 83 : 422 429.
12. Hilmer SN, Mager DE, Simonsick EM et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007 167 : 781 787.
13. Lechevallier-Michel N, Molimard M, Dartigues J-F et al. Drugs with anticholinergic properties and cognitive performance in the elderly: Results from the PAQUID Study. Br J Clin Pharmacol 2004 59 : 143 151.
14. Abrahamowicz M, Bartlett G, Tamblyn R et al. Modeling cumulative dose and exposure duration provided insights regarding the associations between benzodiazepines and injuries. J Clin Epidemiol 2006 59 : 393 403.
15. Newman AB, Haggerty CL, Kritchevsky SB et al. Walking performance and cardiovascular response: Associations with age and morbidity - the Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci 2003 58A : 715 720.
16. Pahor M, Chrischilles EA, Guralnik JM et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994 10 : 405 411.
17. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987 48 : 314 318.
18. Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology 1998 44 : 217 221.
19. Semla TP, Beizer JL, Higbee MD. Geriatric Dosage Handbook, 12th Ed. Hudson, OH : Lexicomp, 2007.
20. Bassuk SS, Murphy JM. Characteristics of the Modified Mini-Mental State Exam among elderly persons. J Clin Epidemiol 2003 56 : 622 628.
21. Yaffe K, Lindquist K, Penninx BW et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003 61 : 76 80.
22. Bland RC, Newman SC. Mild dementia or cognitive impairment: The Modified Mini-Mental State examination (3MS) as a screen for dementia. Can J Psychiatry 2001 46 : 506 510.
23. Correa JA, Perrault A, Wolfson C. Reliable individual change scores on the 3MS in older persons with dementia: Results from the Canadian Study of Health and Aging. Int Psychogeriatr 2001 13 (Suppl 1) : 71 78.
24. Hayden KM, Khachaturian AS, Tschanz JT et al. Characteristics of a two-stage screen for incident dementia. J Clin Epidemiol 2003 56 : 1038 1045.
25. Francis J, Kapoor WN. Delirium in hospitalized elderly. J Gen Intern Med 1990 5 : 65 79.
26. Park HL, O'Connell JE, Thomson RG. A systematic review of cognitive decline in the general elderly population. Int J Geriatr Psychiatry 2003 18 : 1121 1134.
27. Francis J, Martin D, Kapoor WN. A prospective study of delirium in hospitalized elderly. JAMA 1990 263 : 1097 1101.
28. Frisoni GB, Fratiglioni L, Fastbom J et al. Mild cognitive impairment in the population and physical health: Data on 1,435 individuals aged 75 to 95. J Gerontol A Biol Sci Med Sci 2000 55A : M322 M328.
29. Murray AM, Levkoff SE, Wetle TT et al. Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol A Biol Sci Med Sci 1993 48 : M181 M186.
30. Schor JD, Levkoff SE, Lipsitz LA et al. Risk factors for delirium in hospitalized elderly. JAMA 1992 267 : 827 831.
31. Pompei P, Foreman M, Rudberg MA et al. Delirium in hospitalized older persons: Outcomes and predictors. J Am Geriatr Soc 1994 42 : 809 815.
32. Sudore RL, Mehta KM, Simonsick EM et al. Limited literacy in older people and disparities in health and healthcare access. J Am Geriatr Soc 2006 54 : 770 776.
33. Breteler MM, Claus JJ, Grobbee DE et al. Cardiovascular disease and distribution of cognitive function in elderly people: The Rotterdam Study. BMJ 1994 308 : 1604 1608.
34. Breteler MM, van Swieten JC, Bots ML et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology 1994 44 : 1246 1252.
35. Inouye SK, Wagner DR, Acampora D et al. A predictive index for functional decline in hospitalized elderly medical patients. J Gen Intern Med 1993 8 : 645 652.
36. Inouye SK, Viscoli CM, Horwitz RI et al. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 1993 119 : 474 481.
37. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996 275 : 852 857.
38. Hanlon JT, Schmader KE, Landerman LR et al. Relation of prescription nonsteroidal antiinflammatory drug use to cognitive function among community-dwelling elderly. Ann Epidemiol 1997 7 : 87 94.
39. Psaty BM, Koepsell TD, Lin D et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 1999 47 : 749 754.
40. Kasper JD, Simonsick E. Mental health and general well-being. In : Guralnik JM, Fried LP, Simonsick E, eds. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. Bethesda, MD : National Institute on Aging, 1995.
41. Bellamy N, Buchanan WW, Goldsmith CH et al. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988 15 : 1833 1840.
42. McAlindon TE, Wilson PW, Aliabadi P. Level of physical activity and the risk of radiographic and symptomatic knee osteoarthritis in the elderly: The Framingham Study. Am J Med 1999 106 : 151 157.
43. Penninx BWJH, Kritchevsky SB, Yaffe K et al. Inflammatory markers and depressed mood in older persons: Results from the Health, Aging and Body Composition Study. Biol Psychiatry 2003 54 : 566 572.
44. Farrington CP. Interval-censored survival data: A generalized linear modeling approach. Stat Med 1996 15 : 283 292.
45. Hosmer DW, Lemeshow S. Applied Survival Analysis. New York : John Wiley & Sons, Inc, 1999.
46. Kooperberg C, Clarkson DB. Hazard regression with interval-censored data. Biometrics 1996 53 : 1485 1494.
47. Hanlon JT, Boudreau RM, Roumani Y et al. The impact of central nervous system medication dosage on recurrent falls in community elders: The Health, Aging and Body Composition Study. J Gerontol Med Sci 2008 (in press)
48. Kamboj SK, Tookman A, Jones L et al. The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 2005 117 : 388 395.
49. Morrison RS, Magaziner J, Gilbert M et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci 2003 58A : M76 M81.
50. Paleacu D, Shutzman A, Giladi N et al. Effects of pharmacological therapy on gait and cognitive function in depressed patients. Clin Neurpharmacol 2007 30 : 63 71.
51. Podewils LJ, Lyketsos CG. Tricyclic antidepressants and cognitive decline. Psychosomatics 2002 43 : 31 35.
52. Frank R, Wiederholt WC, Kritz-Silverstein DK et al. Effects of sequential neuropsychological testing of an elderly community-based sample. Neuroepidemiol 1996 15 : 257 268.
53. Beglinger LJ, Gaydos B, Tangphao-Daniels O et al. Practice effects and the use of alternate forms in serial neuropsychological testing. Arch Clin Neuropsychol 2005 20 : 517 529.